Chris Bahl Ph.D.
Dr. Chris Bahl is a protein designer, biochemist and structural biologist. Chris pioneered the ability to computationally design synthetic miniproteins de novo. He began this work at the Institute of Protein Design in Seattle as a postdoctoral fellow, and he matured this design technology into a high-throughput platform with his team at the Institute for Protein Innovation in Boston where Chris was the Head of Protein Design. Today, Chris is the Chief Scientific Officer and Co-founder of AI Proteins, Inc. AI Proteins is leveraging the unique and powerful synthetic miniprotein modality to rapidly create novel therapeutics.